Gland Pharma Ltd (GLAND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003443, "name": "Gland Pharma", "stock_name": "Gland Pharma", "full_name": "Gland Pharma Ltd", "name_url": "stocks-analysis/gland-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,941.65", "chg": -20.25, "chgp": "-0.68%", "dir": -1, "prev_price": "2,961.90", "mcapval": "49,130.00 Cr", "mcap": "Small Cap", "scripcode": 543245, "symbol": "GLAND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE068V01023", "curr_date": "Sep 21, 03:30 PM", "curr_time": "07:55 AM", "last_traded_at": "Sep 21, 03:30 PM IST", "bse_nse_vol": "2.96 lacs", "exc_status": "Active", "traded_date": "Sep 21, 2026", "traded_date_str": "2026 09 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Gland Pharma Ltd is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-by-marketsmojo-4192408", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GlandPharmaLtd_mojoScore_4192408.png", "date": "2026-09-14 10:10:32", "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 07 September 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 14 September 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook." }, { "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 3041.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs304195-4185060", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GlandPharmaLtd_priceRelatedfactors_4185060.png", "date": "2026-09-07 11:07:19", "description": "With a decisive surge to Rs 3041.95 on 7 Sep 2026, Gland Pharma Ltd has reached a new 52-week high, extending its impressive 58.44% gain over the past year. This milestone comes amid a broader market downturn, underscoring the stock's strong technical momentum and resilience." }, { "title": "Gland Pharma Gains 1.61%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-gains-161-4-key-factors-driving-the-weeks-momentum-4183417", "imagepath": "", "date": "2026-09-05 12:03:37", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Stock opens steady at Rs.2,888.30 amid Sensex decline</p>\n <p><strong>2 Sep:</strong> Downgrade to Hold rating announced reflecting mixed signals</p>\n <p><strong>3 Sep:</strong> Technical momentum shifts to mildly bullish with mixed indicators</p>\n <p><strong>4 Sep:</strong> High-value trading observed amid narrow price range and renewed bullish momentum</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,886.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-..." }, { "title": "Gland Pharma Ltd Sees High-Value Trading Amid Narrow Price Range and Institutional Caution", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-sees-high-value-trading-amid-narrow-price-range-and-institutional-caution-4182204", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GlandPharmaLtd_most_active_equities_by_value_4182204.png", "date": "2026-09-04 10:00:16", "description": "Gland Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed significant trading activity on 4 September 2026, with a total traded value exceeding ₹41,873.9 lakhs. Despite a slight dip in its share price and a recent downgrade in its Mojo Grade from Buy to Hold, the stock remains a focal point for institutional investors and market participants due to its liquidity and sustained interest." }, { "title": "Gland Pharma Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-to-bullish-amid-strong-price-gains-4181881", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GlandPharmaLtd_technicaldot_4181881.png", "date": "2026-09-04 08:05:41", "description": "Gland Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Supported by robust price action and positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, the pharmaceutical company’s stock is showing renewed strength despite mixed broader market conditions." }, { "title": "Gland Pharma Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4180574", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GlandPharmaLtd_mojoScore_4180574.png", "date": "2026-09-03 08:27:45", "description": "Gland Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 2 September 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong recent financial performance and market-beating returns, evolving technical signals and valuation concerns have tempered the overall outlook." }, { "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4180414", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GlandPharmaLtd_technicaldot_4180414.png", "date": "2026-09-03 08:05:33", "description": "Gland Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early September 2026. Despite a slight dip in daily price, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and on-balance volume. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory." }, { "title": "Gland Pharma Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4173301", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlandPharmaLtd_mojoScore_4173301.png", "date": "2026-08-28 10:10:48", "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 August 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and technical outlook." }, { "title": "Gland Pharma Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-4157700", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlandPharmaLtd_mojoScore_4157700.png", "date": "2026-08-17 10:10:38", "description": "Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 426, "sid": "1003443", "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Acquisition", "datetime": "13-Sep-2026", "details": "Acquisition of Gland Pharma USA Inc. a wholly-owned Step down subsidiary from Gland Pharma International Pte. Ltd a wholly-owned subsidiary of the Company", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting", "datetime": "13-Sep-2026", "details": "Outcome of Board Meeting", "source": "BSE" }, { "caption": "Grant Of Stock Options Under Gland Pharma Employee Stock Option Scheme 2025", "datetime": "13-Sep-2026", "details": "Grant of Stock Options under Gland Pharma Employee Stock Option Scheme 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Gland Pharma Ltd has declared <strong>2000%</strong> dividend, ex-date: 11 Aug 26", "dt": "2026-08-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

31 Aug: Stock opens steady at Rs.2,888.30 amid Sensex decline

2 Sep: Downgrade to Hold rating announced reflecting mixed signals

3 Sep: Technical momentum shifts to mildly bullish with mixed indicators

4 Sep: High-value trading observed amid narrow price range and renewed bullish momentum

Week Open

Rs.2,886.05

Read full news article

Gland Pharma Ltd Sees High-Value Trading Amid Narrow Price Range and Institutional Caution

2026-09-04 10:00:16

Gland Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed significant trading activity on 4 September 2026, with a total traded value exceeding ₹41,873.9 lakhs. Despite a slight dip in its share price and a recent downgrade in its Mojo Grade from Buy to Hold, the stock remains a focal point for institutional investors and market participants due to its liquidity and sustained interest.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains

2026-09-04 08:05:41

Gland Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Supported by robust price action and positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, the pharmaceutical company’s stock is showing renewed strength despite mixed broader market conditions.

Read full news article

Gland Pharma Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-09-03 08:27:45

Gland Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 2 September 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong recent financial performance and market-beating returns, evolving technical signals and valuation concerns have tempered the overall outlook.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-03 08:05:33

Gland Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early September 2026. Despite a slight dip in daily price, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and on-balance volume. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-08-28 10:10:48

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 August 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and technical outlook.

Read full news article

Gland Pharma Ltd is Rated Buy

2026-08-17 10:10:38

Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article